Lipegfilgrastim in patients with chemotherapy-induced neutropenia

G. D. Petrova; Петрова Г. Д.; T. Z. Chernyavskaya; Чернявская Т. З.; N. V. Gorbunova; Горбунова Н. В.; V. N. Kostrykina; Кострыкина В. Н.; V. A. Doronin; Доронин В. А.; K. N. Melkova; Мелкова К. Н.

doi:10.17650/1818-8346-2015-10-4-38-43

Lipegfilgrastim in patients with chemotherapy-induced neutropenia

Authors: Petrova G.D.¹, Chernyavskaya T.Z.¹, Gorbunova N.V.¹, Kostrykina V.N.¹, Doronin V.A.¹, Melkova K.N.¹
Affiliations:
1. N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia
Issue: Vol 10, No 4 (2015)
Pages: 38-43
Section: HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE
Published: 23.12.2015
URL: https://oncohematology.abvpress.ru/ongm/article/view/166
DOI: https://doi.org/10.17650/1818-8346-2015-10-4-38-43
ID: 166

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

The development of dose-limiting toxicities, including myelotoxicity, can significantly limit cytostatic therapy of malignant tumors. Neutropenia associated with high risk of febrile neutropenia (FN) and infectious complications that may interfere with therapy intensity and significantly increases the cost of diagnosis and treatment. With the development of recombinant forms of human granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor, therapy of iatrogenic neutropenia has undergone significant changes. The use of G-CSF (filgrastim, lenograstim, pegfilgrastim) reduces FN incidence in patients receiving myelosuppressive chemotherapy. Until recently, the only original preparation of G-CSF with prolonged action was pegfilgrastim. Lipegfilgrastim (Lonquex, Teva) is a new highly effective long-acting pegylated G-CSF, which has been approved by European Medicines Agency experts for FN prevention in patients receiving chemotherapy. This review summarizes the characteristics of chemical structure, pharmacokinetics, safety and efficacy of lipegfilgrastim.

Keywords

chemotherapy, myelotoxicity, neutropenia, febrile neutropenia, prevention, granulocyte colony-stimulating factor, filgrastim, pegfilgrastim, lipegfilgrastim, Lonquex

References

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Lipegfilgrastim in patients with chemotherapy-induced neutropenia

Full Text

Abstract

Keywords

About the authors

G. D. Petrova

T. Z. Chernyavskaya

N. V. Gorbunova

V. N. Kostrykina

V. A. Doronin

K. N. Melkova

References

Supplementary files